Trade Summary

Yesterday, Mahon Paul A, serving as EVP, GC at United Therapeutics Corp (UTHR), sold 8,300 shares at $485.43 per share, for a total transaction value of $4,029,076.00. Following this transaction, Mahon Paul A now holds 36,781 shares of UTHR.

This sale represents a 18.00% decrease in Mahon Paul A's stake in the company. This is considered a high-conviction trade given the significant change in ownership.

The trade was executed on Friday, January 2, 2026 and publicly disclosed via SEC Form 4 filing on Friday, January 2, 2026, meaning the disclosure happened on the same day as the trade.

United Therapeutics Corp operates in the HEALTHCARE sector, specifically within the DRUG MANUFACTURERS - SPECIALTY & GENERIC industry. Insider selling activity in this sector can provide valuable signals about industry trends and company-specific developments.